Introduction
Amyloid PET-CT is an advanced molecular imaging test used to detect amyloid plaques in the brain, a key pathological feature associated with Alzheimer’s disease and certain other neurodegenerative conditions.
The scan allows physicians to visualize amyloid protein accumulation in living patients, supporting accurate diagnosis and differentiation of cognitive disorders.
Amyloid PET-CT does not diagnose dementia on its own but provides critical information when combined with clinical evaluation, cognitive testing, and other neurological investigations.
It is especially valuable in patients with unexplained cognitive decline, atypical symptoms, or early-onset memory disorders.
Türkiye is a trusted destination for advanced neuroimaging, offering modern amyloid PET-CT technology, experienced nuclear medicine specialists, and integrated neurology care.
Averia Health supports international patients through ethical, structured, and fully coordinated amyloid PET-CT services focused on diagnostic clarity and patient reassurance.
Why Choose Türkiye for Amyloid PET-CT
Türkiye is internationally recognized for high-quality neuroimaging and nuclear medicine services because of:
- Advanced PET-CT scanners optimized for brain imaging
- Availability of amyloid-specific PET tracers
- Experienced nuclear medicine physicians and neuroradiology collaboration
- Strict radiation safety and quality assurance standards
- Multidisciplinary coordination with neurology and memory clinics
- Internationally accredited hospitals
Türkiye combines advanced imaging technology with expert neurological interpretation.
Why Choose Averia Health
Averia Health provides comprehensive coordination for amyloid PET-CT scans:
- Pre-arrival review of medical history, cognitive symptoms, and prior tests
- Referral to accredited nuclear medicine centers with amyloid imaging expertise
- Clear explanation of the scan’s purpose, benefits, and limitations
- Coordination with neurologists and memory disorder specialists
- Professional interpreter services
- 24/7 patient support during your visit
- Timely reporting and international follow-up coordination
Our approach prioritizes transparency, ethical care, and informed decision-making.
Conditions Evaluated with Amyloid PET-CT
Amyloid PET-CT is primarily used to support evaluation of:
- Suspected Alzheimer’s disease
- Mild cognitive impairment (MCI) of unclear cause
- Early-onset cognitive decline
- Atypical or mixed dementia presentations
- Differentiation between Alzheimer’s disease and non-amyloid dementias
- Cognitive symptoms with inconclusive conventional testing
The scan is recommended based on neurological assessment and clinical need.
Role of Amyloid PET-CT in Cognitive Disorders
Detection of Amyloid Plaques
Identifies abnormal amyloid protein accumulation in the brain.
Diagnostic Clarification
Supports or excludes Alzheimer’s pathology as a cause of symptoms.
Treatment Planning
Helps guide appropriate management, counseling, and future planning.
Research and Advanced Care Pathways
Used in selected patients for advanced diagnostic clarification.
Results are interpreted in the context of clinical findings rather than in isolation.
Diagnostic Evaluation Before Amyloid PET-CT
Preparation and evaluation may include:
- Neurology or memory clinic consultation
- Review of cognitive testing and prior brain imaging (MRI or CT)
- Medication and medical history review
- Assessment of pregnancy or breastfeeding when relevant
- Explanation of tracer use and scan limitations
Proper evaluation ensures appropriate use of amyloid imaging.
Amyloid PET-CT Scan Journey in Türkiye
- Pre-Arrival Case Review
Medical history and neurological indications are reviewed in advance. - Nuclear Medicine Consultation
The procedure, tracer mechanism, and expectations are explained clearly. - Amyloid Tracer Administration
A small amount of amyloid-specific radiotracer is administered safely. - PET-CT Brain Imaging
High-resolution brain imaging is performed using advanced PET-CT systems. - Image Interpretation
Scans are analyzed by experienced nuclear medicine specialists. - Results & Neurology Coordination
Findings are shared with the treating neurologist for clinical interpretation.
Expected Results & Benefits
- Objective assessment of brain amyloid burden
- Improved diagnostic confidence in cognitive disorders
- Differentiation between Alzheimer’s and non-Alzheimer’s causes
- Support for personalized care planning
- Reduced diagnostic uncertainty for patients and families
A negative amyloid PET scan can be as clinically valuable as a positive one.
Risks & Considerations
Amyloid PET-CT is safe and well established. Considerations include:
- Exposure to a low level of radiation
- Temporary discomfort from tracer injection
- Results must be interpreted alongside clinical findings
- Amyloid presence does not always correlate with symptom severity
The test is used selectively to ensure clinical value.
What’s Included in Your Medical Visit
- Amyloid PET-CT scan appointment
- Nuclear medicine consultation
- Amyloid-specific tracer administration
- PET-CT brain imaging and expert interpretation
- Written diagnostic report
- Coordination with neurology or memory specialists
- Interpreter services
- Patient support and follow-up coordination
Averia Health ensures ethical, precise, and patient-centered neuroimaging care.
Frequently Asked Questions
Does amyloid PET-CT diagnose Alzheimer’s disease?
It detects amyloid plaques, which support diagnosis when combined with clinical evaluation.
Can a normal scan rule out Alzheimer’s disease?
A negative scan makes Alzheimer’s pathology unlikely.
Is amyloid PET-CT safe?
Yes. Radiation exposure is controlled and within medical standards.
Who should consider this scan?
Patients with unexplained or atypical cognitive decline after specialist evaluation.
How quickly will results be available?
Results are typically available shortly after expert interpretation.
Ready to Start Your Health Journey?
Gain clarity in cognitive diagnosis with advanced amyloid PET-CT imaging in Türkiye.
Request a free case review or contact us on WhatsApp to speak with our diagnostic care coordination team.
